Targeting Insulin Signaling for the Treatment of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|5|485-492

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.5, 2016-02, pp. : 485-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting insulin-like growth factor-1 to treat Alzheimer's disease

By Torres-Aleman Ignacio  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1535-1542

Informa Healthcare

Access to resources Recommend Favorite

Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 24, 2016-07 ,pp. : 2770-2788

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2899-2911

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Insulin Resistance in the Pathogenesis of Alzheimer's Disease: Implications for Treatment

By Watson G.S.  

CNS Drugs, Vol. 17, Iss. 1, 2003-01 ,pp. : 27-45

Adis International

Access to resources Recommend Favorite

Insulin resistance and Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite